The induction strategies administered in the treatment of multiple myeloma exhibit a deleterious effect on the endothelium
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The induction strategies administered in the treatment of multiple myeloma exhibit a deleterious effect on the endothelium
Authors
Keywords
-
Journal
BONE MARROW TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-14
DOI
10.1038/s41409-020-0947-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Up‐regulation of HDACs, a harbinger of uraemic endothelial dysfunction, is prevented by defibrotide
- (2019) Marta Palomo et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Acute Graft-vs.-Host Disease-Associated Endothelial Activation in vitro Is Prevented by Defibrotide
- (2019) Julia Martinez-Sanchez et al. Frontiers in Immunology
- Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation
- (2018) Gonzalo Gutiérrez-García et al. BONE MARROW TRANSPLANTATION
- The multiple myeloma treatment landscape: international guideline recommendations and clinical practice in Europe
- (2018) Michele Cavo et al. Expert Review of Hematology
- Venous thromboembolism in multiple myeloma - choice of prophylaxis, role of direct oral anticoagulants and special considerations
- (2018) Dawn Swan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Dexamethasone suppresses JMJD3 gene activation via a putative negative glucocorticoid response element and maintains integrity of tight junctions in brain microvascular endothelial cells
- (2017) Wonho Na et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Hematopoietic Stem Cell Transplantation for Multiple Myeloma
- (2017) Heather L. Koniarczyk et al. Seminars in Oncology Nursing
- Immune-Mediated Complications after Hematopoietic Stem Cell Transplantation
- (2016) Zhuoyan Li et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- What is going on between defibrotide and endothelial cells? Snapshots reveal the hot spots of their romance
- (2016) M. Palomo et al. BLOOD
- Bortezomib Effects on Human Microvascular Endothelium in vitro
- (2016) Abha Sahni et al. PHARMACOLOGY
- Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation
- (2015) Ayman Akil et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Thalidomide and multiple myeloma serum synergistically induce a hemostatic imbalance in endothelial cells in vitro
- (2015) Yujuan Gao et al. THROMBOSIS RESEARCH
- The proteasome inhibitor bortezomib induces testicular toxicity by upregulation of oxidative stress, AMP-activated protein kinase (AMPK) activation and deregulation of germ cell development in adult murine testis
- (2015) Wei Li et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Proteasome inhibitors - molecular basis and current perspectives in multiple myeloma
- (2014) Lenka Kubiczkova et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Distinct Deleterious Effects of Cyclosporine and Tacrolimus and Combined Tacrolimus–Sirolimus on Endothelial Cells: Protective Effect of Defibrotide
- (2013) Alba Carmona et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Divergent Effects of Novel Immunomodulatory Agents and Cyclophosphamide on the Risk of Engraftment Syndrome after Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma
- (2013) Robert Frank Cornell et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Defibrotide: Properties and clinical use of an old/new drug
- (2013) R. Pescador et al. VASCULAR PHARMACOLOGY
- Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study
- (2012) L. Rosinol et al. BLOOD
- Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma
- (2012) Yuan Xiao Zhu et al. LEUKEMIA & LYMPHOMA
- The role of the endothelium in the short-term complications of hematopoietic SCT
- (2011) E Carreras et al. BONE MARROW TRANSPLANTATION
- Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: Role of the Conditioning Regimen and the Type of Transplantation
- (2010) Marta Palomo et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease and Multiorgan Failure after Stem Cell Transplantation: A Multicenter, Randomized, Dose-Finding Trial
- (2010) Paul G. Richardson et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Defibrotide Prevents the Activation of Macrovascular and Microvascular Endothelia Caused by Soluble Factors Released to Blood by Autologous Hematopoietic Stem Cell Transplantation
- (2010) Marta Palomo et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center
- (2010) E Carreras et al. BONE MARROW TRANSPLANTATION
- Thalidomide inhibits inflammatory and angiogenic activation of human intestinal microvascular endothelial cells (HIMEC)
- (2009) Parvaneh Rafiee et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- The Release of Soluble Factors Contributing to Endothelial Activation and Damage after Hematopoietic Stem Cell Transplantation Is Not Limited to the Allogeneic Setting and Involves Several Pathogenic Mechanisms
- (2009) Marta Palomo et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Potent anti-inflammatory effects of low-dose proteasome inhibition in the vascular system
- (2009) Antje Ludwig et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- VE-Cadherin
- (2007) Dietmar Vestweber ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started